Drug Type Small molecule drug |
Synonyms Nisoldipine (JAN/USAN/INN), isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate + [14] |
Target |
Action inhibitors |
Mechanism Cav2.1 inhibitors(calcium voltage-gated channel subunit alpha1 A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (02 Feb 1995), |
Regulation- |
Molecular FormulaC20H24N2O6 |
InChIKeyVKQFCGNPDRICFG-UHFFFAOYSA-N |
CAS Registry63675-72-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00618 | Nisoldipine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | United States | 02 Feb 1995 |
Phase 4 | 48 | (luxilztyyy) = qznuzpulmn ufcyhvmzkd (pfriamprmz ) View more | - | 01 Dec 2000 | |||
(luxilztyyy) = mwbfueorrk ufcyhvmzkd (pfriamprmz ) View more |